Correspondence

Invasive aspergillosis is an emerging infection mainly affecting immunocompromised patients. This report details a case of Aspergillus fumigatus tricuspid native valve endocarditis complicated by recurrent septic pulmonary emboli in a young, non-intravenous drug user. He was treated by surgical resection of the posterior leaflet of the tricuspid valve and the vegetations, as well as by valvuloplasty, which was followed by a combination of liposomal amphotericin B and voriconazole as acute-phase therapy and voriconazole alone as suppression therapy. Case report A 25-year-old man was admitted to hospital with fever, progressive dyspnoea, thoracic pain and bloody sputum. His past medical history was noteworthy for bronchial asthma, for which he had been receiving steroids for a period of 6 months (3 months systematically and 3 months inhaled) during the year prior to admission. In addition, he received antibiotics on six occasions for postulated respiratory infections during the year prior to admission. H